B cells and autoantibodies in the pathogenesis of hypertension

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1144243

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project aims to gain a better understanding of the causes of hypertension. Specifically, we will test the idea that activation of the immune system and the production of antibodies is a major cause of the blood vessel and kidney damage that leads to high blood pressure. Such findings could pave the way for new treatment approaches where drugs currently reserved for patients with autoimmune diseases (e.g. rheumatoid arthritis, gout) are re-purposed for the treatment of hypertension.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2021

Funding Scheme: Project Grants

Funding Amount: $853,340.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Basic Pharmacology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

B cells | autoantibodies | cytokines | hypertension | inflammation

Related Links